Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2011 1
2012 2
2013 2
2014 1
2015 1
2016 3
2017 2
2018 3
2019 2
2020 2
2021 1
Text availability
Article attribute
Article type
Publication date

Search Results

15 results
Results by year
Filters applied: . Clear all
Page 1
Association of peripheral nesfatin-1 with early stage diabetic nephropathy.
Irannejad A, Ghajar A, Afarideh M, Khajeh E, Noshad S, Esteghamati S, Afshari K, Kahe F, Ganji M, Saadat M, Nakhjavani M, Esteghamati A. Irannejad A, et al. Among authors: esteghamati s. Pathophysiology. 2017 Mar;24(1):17-22. doi: 10.1016/j.pathophys.2016.12.001. Epub 2016 Dec 13. Pathophysiology. 2017. PMID: 28038936
Sitagliptin vs. pioglitazone as add-on treatments in patients with uncontrolled type 2 diabetes on the maximal dose of metformin plus sulfonylurea.
Khaloo P, Asadi Komeleh S, Alemi H, Mansournia MA, Mohammadi A, Yadegar A, Afarideh M, Esteghamati S, Nakhjavani M, Esteghamati A. Khaloo P, et al. Among authors: esteghamati s. J Endocrinol Invest. 2019 Jul;42(7):851-857. doi: 10.1007/s40618-018-0991-0. Epub 2018 Dec 10. J Endocrinol Invest. 2019. PMID: 30535871 Clinical Trial.
Associations of Serum S100B and S100P With the Presence and Classification of Diabetic Peripheral Neuropathy in Adults With Type 2 Diabetes: A Case-Cohort Study.
Afarideh M, Zaker Esteghamati V, Ganji M, Heidari B, Esteghamati S, Lavasani S, Ahmadi M, Tafakhori A, Nakhjavani M, Esteghamati A. Afarideh M, et al. Among authors: esteghamati s. Can J Diabetes. 2019 Jul;43(5):336-344.e2. doi: 10.1016/j.jcjd.2019.01.003. Epub 2019 Jan 11. Can J Diabetes. 2019. PMID: 30872108
15 results